Next Article in Journal
The Characteristics of Cognitive Proficiency in Patients with Acute Neuromyelitis Optica Spectrum Disease and its Correlation with Serum Aquaporin-4 Antibody Titer
Previous Article in Journal
The Creative Drummer: An EEG-Based Pilot Study on the Correlates of Emotions and Creative Drum Playing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Morphology of the Pituitary Gland: A Meta-Analysis with Implications for Diagnostic Imaging

1
Department of Anatomy, Jagiellonian University Medical College, 33-332 Kraków, Poland
2
Department of Normal and Clinical Anatomy, Chair of Anatomy and Histology, Medical University of Lodz, 90-752 Łódź, Poland
3
Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland
4
Department of Normal and Clinical Anatomy, Institute of Medical Sciences, Medical College of Rzeszow University, 35-315 Rzeszów, Poland
5
Department of Neurosurgery, Spine and Peripheral Nerves Surgery, Medical University of Lodz, 90-549 Łódź, Poland
6
Faculty of Philology, Department of Polish Dialectology and Logopedics, University of Lodz, 90-236 Łódź, Poland
7
Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz, 90-001 Łódź, Poland
*
Author to whom correspondence should be addressed.
Brain Sci. 2023, 13(1), 89; https://doi.org/10.3390/brainsci13010089
Submission received: 30 November 2022 / Revised: 24 December 2022 / Accepted: 28 December 2022 / Published: 2 January 2023
(This article belongs to the Section Neurosurgery and Neuroanatomy)

Abstract

:
The objective of this meta-analysis was to present transparent data on the morphology of the pituitary gland (PG) using the available data in the literature. The main online medical databases, such as PubMed, Embase, Scopus, and Web of Science, were searched to gather all relevant studies regarding PG morphology. The mean overall volume of the PG was found to be 597.23 mm3 (SE = 28.81). The mean overall height of the PG was established to be 5.64 mm (SE = 0.11). The mean overall length of the PG was found to be 9.98 mm (SE = 0.26). In the present study, the PG’s overall morphology and morphometric features were analyzed. Our results showed that, on average, females from Asia have the highest volume of PG (706.69 mm3), and males from Europe have the lowest (456.42 mm3). These values are crucial to be aware of because they represent the normal average properties of the PG, which may be used as reference points when trying to diagnose potential pathologies of this gland. Furthermore, the present study’s results prove how the PG’s size decreases with age. The results of the present study may be helpful for physicians, especially surgeons, performing procedures on the PG.

1. Introduction

The pituitary gland (PG) is a small bean-shaped organ located at the base of the brain. It was termed the “master gland” because of the numerous hormones that emanate from it and help to regulate vital functions such as the growth of various tissues, blood pressure, and reproduction. It is located in the sella turcica, which is the saddle-like bony formation on the upper surface of the body of the sphenoid. The PG consists of the anterior pituitary lobe (or adenohypophysis), the intermediate lobe, and the posterior pituitary lobe (or neurohypophysis).
During the fourth week of gestation, Rathke’s pouch originates from the roof of the stomodeum. It proliferates to produce the pars distalis (anterior pituitary), the pars intermedia (intermediate lobe), and the pars tuberalis [1,2]. Furthermore, between the fifth and sixth week of gestation, the diencephalon neuroectoderm produces the median eminence, the infundibular stem, and the pars nervosa [3].
The “norm” in anatomy is not as precise a concept as one would wish and could be considered an approximation [4]. It is known that pituitary size depends on age, gender, certain diseases, and even race. There is a trend for larger pituitary volumes among females and during puberty, followed by a progressive decrease in size after adolescence [5]. Furthermore, pituitary height was proposed as the best single surrogate parameter of pituitary size and is maximal in young adults and changes with chronic functional alterations [6]. PG volume may also change in patients with various nutritional disorders and neuroendocrine and psychiatric diseases such as schizophrenia, depression, and psychotic disorders [7,8,9,10]. Moreover, morphological changes in the PG due to hormone-related factors, such as the intake of estrogens, pregnancy, and the postpartum phase, have also been a repeated topic of discussion [11,12]. Magnetic resonance imaging (MRI) allows for a detailed examination of PG morphology because of its excellent contrast resolution. Some of the standard methods used in MRI measuring the PG volume are based on stereological techniques using point counting, planimetry, and the elliptic formula [13].
Pituitary disorders cause a broad spectrum of hormonal and neurological symptoms due to the gland’s location close to vital neurovascular structures and the essential hormonal control it provides [14]. Therefore, the objective of this meta-analysis was to present transparent data on the morphology of the PG using the available data in the literature. These results could provide physicians with reliable knowledge about the PG’s morphology and morphometry, enabling the recognition of pathological changes in the gland.

2. Materials and Methods

2.1. Search Strategy

The main online medical databases, such as PubMed, Embase, Scopus, and Web of Science, were searched to gather all relevant studies regarding PG morphology. The following search terms were used: ((pituitary gland) OR ((hypophysis)) AND (anatomy))) OR ((pituitary gland[Title/Abstract]) AND (morphometry[Title/Abstract])). The search terms were adjusted for each database to maximize the number of studies found. The date, language, article type, and text availability conditions were not applied. An additional search was conducted through the references of the identified studies at the end of the search stage to ensure the precision of the process. The preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines were followed during the study. The critical appraisal tool for anatomical meta-analysis (CATAM) was also used to provide the highest-quality findings [15].

2.2. Eligibility Assessment

Initially, after the search of the databases and an additional manual search through the references, 21,365 studies were identified and first reviewed by two independent reviewers. After removing the duplicates and irrelevant records, a total of 318 articles qualified for the full-text evaluation. Papers such as case reports, case series, conference reports, reviews, letters to editors, and studies that provided incomplete or irrelevant data were excluded to minimize potential bias and maintain an accurate statistical methodology. The inclusion criteria involved original studies, both cadaveric and based on radiological imagining, with extractable numerical data on the morphology of the PG. Studies examining the PG in only one dimension were also considered. The results obtained on the cadavers did not differ statistically significantly from those obtained using magnetic resonance imaging (p > 0.05); therefore, an overall analysis could be performed. A total of 247 articles were excluded from the study because they were case reports or case series (n = 38) or because they did not have relevant or sufficient data regarding the morphometric parameters of the PG (n = 210). Finally, a total of 72 studies were included in this meta-analysis. The AQUA Tool, which was specifically designed for anatomical meta-analyses, was used to minimize the potential bias of the included studies [16]. The data collection process is shown in Figure 1. The characteristics of the studies included in this meta-analysis are gathered in Table 1.

2.3. Data Extraction

Two independent reviewers performed the extraction. Qualitative data, such as the year of publication, country, and continent, were gathered. Quantitative data, such as the sample size and numerical data regarding the morphological aspects of the PG in specific groups, were gathered. Any discrepancies between the studies identified by the two reviewers were resolved by contacting the authors of the original studies wherever possible or by consensus with a third reviewer.

2.4. Statistical Analysis

To perform this meta-analysis, STATISTICA version 13.1 software (StatSoft Inc., Tulsa, OK, USA), MetaXL version 5.3 software (EpiGear International Pty Ltd, Wilston, Queensland, Australia), and Comprehensive Meta-analysis version 3.0 software (Biostat Inc., Englewood, NJ, USA) were applied. A random effects model was used. The Chi-square test and the I-squared statistic were chosen to assess the heterogeneity among the studies [15]. P-values and confidence intervals were used to determine the statistical significance between the studies. A p-value lower than 0.05 was considered statistically significant. In the event of overlapping confidence intervals, the differences were considered statistically insignificant. I-squared statistics were interpreted as follows: values of 0–40% were considered as “might not be important”, values of 30–60% were considered as “might indicate moderate heterogeneity”, values of 50–90% were considered as “may indicate substantial heterogeneity”, and values of 75–100% were considered as “may indicate substantial heterogeneity.” The results obtained on the cadavers did not differ statistically significantly from those obtained using magnetic resonance imaging (p > 0.05). Therefore, an overall analysis could be performed.

3. Results

3.1. Morphometric Parameters of the PG in Adults

The mean overall volume of the PG was 597.23 mm3 (SE = 28.81). The mean overall height of the PG was 5.64 mm (SE = 0.11). The mean overall length of the PG was 9.98 mm (SE = 0.26). The mean overall width of the PG was determined at 13.08 mm (SE = 1.76). The mean overall pituitary area was 38.06 mm3 (SE = 2.32). The width of the infundibulum was determined at 2.10 mm (SE = 0.07). The most common shape of the PG was convex with a prevalence of 58.38% (CI: 22.21%–90.65%), followed by concave 17.72% (CI: 5.63%–34.00%) and flat 16.67% (CI: 0.00%–47.07%). Partially empty sella turcica occurred with a prevalence of 2.20% (CI: 0.00%–7.16%). The p-value in every category equaled < 0.001. All the results mentioned above, and more detailed results, including sexual dimorphisms and intercontinental differences, are gathered in Table 2.

3.2. Morphometric Parameters of the PG in Children (under 18 Years Old)

The mean overall volume of the PG was 511.53 mm3 (SE = 112.45). The mean overall height of the PG was 4.81 mm (SE = 0.55). The mean width of the PG was determined at 10.80 mm (SE = 0.07) in Asian children. The mean pituitary area was 29.98 mm3 (SE = 1.10) in Asian children. The most frequent shape of the PG was convex, with a prevalence of 54.03% (CI: 22.55%–84.05%), followed by flat 33.10% (CI: 7.87%–64.05%). The prevalence of the concave shape was determined to be 12.16% (CI: 6.92%–18.58%). The p-value in every category was < 0.001. All the results mentioned above, and more detailed results, including sexual dimorphisms and intercontinental differences, are gathered in Table 3.

3.3. PG Height concerning the Age Groups of the Patients

The results concerning the height of the PG in different age groups were also collected. The detailed statistical data are gathered in Table 4. A graphical representation of the differences in the heights of the PG between male and female patients and between different age groups is displayed in Figure 2.

4. Discussion

The PG is a pea-sized gland that sits in the hypophyseal fossa of the sphenoid bone and is surrounded by the sella turcica, covered by the dural fold (diaphragma sellae) (Figure 3). In humans, it comprises two main lobes, anterior and posterior, with the intermediate lobe joining them together.
During the first two decades of life, the PG grows rapidly and weighs approximately 500 mg by 20 years of age [3,81]. However, with time, significant interstitial fibrosis of the pituitary tissue develops, leading to decreased proportions of the gland [81]. Furthermore, the PG goes through considerable changes in size during pregnancy. It was proven that during pregnancy, the PG becomes somewhat hyperintense on T1-weighted images (one of the basic pulse sequences in MRI that demonstrates the differences in the T1 relaxation times of tissues), similar to that described for neonates [81,82].
The morphological properties of the PG vary considerably in the general population. Singh et al. conducted a study analyzing the morphometry of the PG using MRI [24]. In the study, the authors stated that the differences in the mean pituitary height and volume between females and males were statistically significant. The mean PG height was reported to be 5.80 ± 1.32 mm and 5.37 ± 1.25 mm for females and males, respectively. Another study by Suzuki et al. presented lower results concerning the height of the PG (5.0 ± 1.7 mm in women and 4.7 ± 1.4 mm in men) [74]. Denk et al. [83], in turn, reported higher values than those in the studies mentioned above (6.1 ± 0.1 mm in women and 5.6 ± 0.2 mm in men). Although the PG height varies between the studies, on average, it is greater in females than in males. Our meta-analysis provides similar results, where females had higher PGs than males (5.40 ± 0.14 mm in women and 4.96 ± 0.12 mm in males).
In the present study, we highlight how the height of the PG changes throughout life. On average, women had taller PGs. However, in females and males, the height peaked in the age group of 20 to 29. With time, the height decreased substantially in females and males, proving that the PG decreases in size throughout life. However, some studies have reported an increase in pituitary height again during the fifth decade of life, especially in females [24,61,67]. The increased activity of gonadotrophs explained this phenomenon in older women due to the loss of negative feedback by gonadal steroids [24]. However, Singh et al. presented an increase in the height of the PG in males [24]. Unfortunately, the mechanism behind this phenomenon is still unknown. However, it may be similar to the one in females, though the phenomenon of andropause in males is not as well understood as menopause in females. Interestingly, our meta-analysis showed that the increase in the height of the PG after the fifth decade of life happened in males only. Furthermore, the average volume of the PG was also analyzed in different populations. Interestingly, the largest PG volume was found to be present in females from Asia (706.69 mm3), and the lowest was found in males from Europe (456.42 mm3). These values are crucial to be aware of because they represent the typical average properties of the PG, which may be used as reference points when trying to diagnose potential pathologies of this gland.
Knowledge of the anatomy of the PG and its morphometric properties is of immense importance when performing surgical procedures on it or in the area of the sella turcica. Pituitary adenomas account for approximately 10–15% of surgically treated central nervous system tumors [84]. The standard approach to the pituitary area is the transsphenoidal midline route, which avoids brain retraction and is known to be less traumatic. In this approach, endoscopes are commonly used as the sole visualizing tool. However, if the pituitary tumor has considerable suprasellar and parasellar extension, the transcranial approach might be more suitable [85].
The PG may be the subject of numerous incidental and benign conditions. These include cysts, which are incidentally found in approximately 10% to 20% of the population [86], rounded calcifications in the gland, or pituitary stones, that do not present as clinically significant findings [3]. A somewhat controversial pathology of the PG is the empty sella. This phenomenon was first described in the 1950s [87]. It is believed to be caused by a weakening of the diaphragma sella. This, in turn, enables the transmission of the cerebrospinal fluid pulsations in the suprasellar cistern to the intrasellar area [3]. This ultimately leads to an incomplete or complete flatting of the PG and, with that, a loss of physiological functioning of the gland.
The relation between the morphology of the PG and various degenerative pathologies, such as Alzheimer’s disease (AD), has been a topic of interest in the literature. One protein that is said to play a role in the pathogenesis of AD and Creutzfeldt-Jakob disease is clusterin [88]. Clusterin, or apolipoprotein J, is a circulating glycoprotein with numerous functions, such as lipid transport and immune modulation [89]. An age-dependent increase of clusterin in the PG was studied by Ishikawa et al. [90] in an immunohistochemical study. They found a positive correlation between the age of the subjects in years and the percentage of clusterin-positive cell area in the anterior lobe of the PG. However, there was no statistical relationship between the clusterin levels and gender. These results suggest that PG clusterin is produced following degenerative changes.
However, the mechanism of this phenomenon is still unclear. The role of the hypothalamic-pituitary axis in Alzheimer’s disease was also discussed previously. Interestingly, there is a gender-biased predisposition towards females specific to AD [90]; therefore, the role of sex steroids regulated by the hypothalamus-pituitary-gonadal axis was investigated. Evidence has suggested that estrogen deficiency, which follows menopause, may contribute to the pathogenesis of AD [91]. Estrogen synthesis and secretion from the theca interna cells in the ovary are mainly stimulated by the luteinizing hormone produced in the anterior PG. Therefore, potential pathologies of the PG, such as hypopituitarism, may cause a decrease in the synthesis and secretion of luteinizing hormone and, subsequently, cause decreased estrogen levels. This mechanism may potentially lead to an increased risk of developing AD. Hypopituitarism is most commonly caused by pituitary adenomas, which may be diagnosed with imaging studies. Our study may be helpful for physicians diagnosing the previously mentioned neoplasms because we provide standard morphometric data of the PG, which may be used as the reference point when comparing measured values of a PG with an adenoma.
Thyroid dysfunction could be a potential risk factor for dementia development; numerous epidemiological data implicates both hyperthyroidism and hypothyroidism [92,93]. Yong-Hong et al. [93] conducted a study where the hypothalamic-pituitary-thyroid axis was assessed. The study showed that the patients with AD had significantly lower thyroid-releasing (TRH) and thyroid-stimulating (TSH) hormones, total and free triiodothyronine, and total and free tetraiodothyronine when compared to the control group. These results present how AD may be associated with the lowered function of the hypothalamic-pituitary-thyroid axis.
The present study is not without limitations. It may be burdened with potential bias, as the accuracy of the data taken from various publications limits the results of this meta-analysis. Additionally, most of the evaluated studies come from Asia. The total number of PG’s analyzed from Asia equaled 1203, while from Europe, there were 1186, and from North America, there were 1093. Therefore, the overall results of this study may be burdened, as they may reflect the anatomical features of Asian people rather than the global population. Variations of organs’ shape and dimensions are frequently observed by medical professionals and could influence daily clinical practice, including imaging diagnostics, therapeutic decisions, and surgical procedures [4]. Although not without limitations, our meta-analysis attempts to estimate pituitary morphology based on the data from the literature that meet the requirements of evidence-based anatomy.

5. Conclusions

The present study analyzed the morphology and morphometric features of the PG. Our results show that, on average, females from Asia have the highest volume of PG (706.69 mm3), and males from Europe have the lowest (456.42 mm3). These values are crucial to be aware of because they represent the normal average properties of the PG, which may be used as reference points when trying to diagnose potential pathologies of this gland. Furthermore, the present study’s results prove how the PG’s size decreases with age. The results of the present study may be helpful for physicians, especially surgeons, performing procedures on the PG.

Author Contributions

M.B., data analysis, tables, figures, and writing; G.W., data analysis, visualization (Figure 3), writing and editing; P.O., data analysis and writing; M.M., literature search data extraction; D.P., data extraction; J.W. (Jakub Wilk), literature search and writing; W.M., literature search and writing; J.W. (Jerzy Walocha), resources, data analysis, figures, and writing; K.B., literature search and data extraction; T.I., writing; D.L., writing; M.K., data analysis, tables, and writing; M.R., resources, data analysis, writing, and editing; A.Ż., data analysis and writing. All authors have read and agreed to the published version of the manuscript.

Funding

The author(s) received no financial support for the research, authorship, and publication of this article. Dr Mateusz Koziej was supported (a scholarship) by the Foundation for Polish Science (FNP). The funders had no role in the study’s design, data collection and analysis, decision to publish, or preparation of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dalley, A.F.; Agur, A. Moore’s Clinically Oriented Anatomy, 9th ed.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2023. [Google Scholar]
  2. Moore, K.L.; Persaud, T.V.N.; Torchia, M.G. The Developing Human: Clinically Oriented Embryology, 11th ed.; Elsevier: Oxford, UK, 2019. [Google Scholar]
  3. Amar, A.P.; Weiss, M.H. Pituitary Anatomy and Physiology. Neurosurg. Clin. N. Am. 2003, 14, 11–23. [Google Scholar] [CrossRef] [PubMed]
  4. Żytkowski, A.; Tubbs, R.S.; Iwanaga, J.; Clarke, E.; Polguj, M.; Wysiadecki, G. Anatomical Normality and Variability: Historical Perspective and Methodological Considerations. Transl. Res. Anat. 2021, 23, 100105. [Google Scholar] [CrossRef]
  5. Chen, H.H.; Nicoletti, M.; Sanches, M.; Hatch, J.P.; Sassi, R.B.; Axelson, D.; Brambilla, P.; Keshavan, M.S.; Ryan, N.; Birmaher, B.; et al. Normal Pituitary Volumes in Children and Adolescents with Bipolar Disorder: A Magnetic Resonance Imaging Study. Depress. Anxiety 2004, 20, 182–186. [Google Scholar] [CrossRef] [PubMed]
  6. Maier, C.; Riedl, M.; Clodi, M.; Bieglmayer, C.; Mlynarik, V.; Trattnig, S.; Luger, A. Dynamic Contrast-Enhanced MR Imaging of the Stimulated Pituitary Gland. Neuroimage 2004, 22, 347–352. [Google Scholar] [CrossRef] [PubMed]
  7. Gruner, P.; Christian, C.; Robinson, D.G.; Sevy, S.; Gunduz-Bruce, H.; Napolitano, B.; Bilder, R.M.; Szeszko, P.R. Pituitary Volume in First-Episode Schizophrenia. Psychiatry Res. Neuroimaging 2012, 203, 100–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Klomp, A.; Koolschijn, P.C.M.P.; Hulshoff Pol, H.E.; Kahn, R.S.; van Haren, N.E.M. Hypothalamus and Pituitary Volume in Schizophrenia: A Structural MRI Study. Int. J. Neuropsychopharmacol. 2012, 15, 281–288. [Google Scholar] [CrossRef] [Green Version]
  9. MacMaster, F.P.; Kusumakar, V. MRI Study of the Pituitary Gland in Adolescent Depression. J. Psychiatr. Res. 2004, 38, 231–236. [Google Scholar] [CrossRef] [PubMed]
  10. Nicolo, J.-P.; Berger, G.E.; Garner, B.A.; Velakoulis, D.; Markulev, C.; Kerr, M.; McGorry, P.D.; Proffitt, T.-M.; McConchie, M.; Pantelis, C.; et al. The Effect of Atypical Antipsychotics on Pituitary Gland Volume in Patients with First-Episode Psychosis: A Longitudinal MRI Study. Schizophr. Res. 2010, 116, 49–54. [Google Scholar] [CrossRef]
  11. Slaus, M. Age and Sex Related Differences in Normal Pituitary Gland and Fossa Volumes. Front. Biosci. 2017, 9, 796. [Google Scholar] [CrossRef] [Green Version]
  12. Miki, Y.; Kataoka, M.L.; Shibata, T.; Haque, T.L.; Kanagaki, M.; Shimono, T.; Okada, T.; Hiraga, A.; Nishizawa, S.; Ueda, H.; et al. The Pituitary Gland: Changes on MR Images During the 1st Year after Delivery. Radiology 2005, 235, 999–1004. [Google Scholar] [CrossRef] [PubMed]
  13. Ertekin, T.; Acer, N.; Turgut, A.T.; Aycan, K.; Özçelik, Ö.; Turgut, M. Comparison of Three Methods for the Estimation of the Pituitary Gland Volume Using Magnetic Resonance Imaging: A Stereological Study. Pituitary 2011, 14, 31–38. [Google Scholar] [CrossRef] [PubMed]
  14. Banas, A.; Banas, K.; Furgal-Borzych, A.; Kwiatek, W.M.; Pawlicki, B.; Breese, M.B.H. The Pituitary Gland under Infrared Light—In Search of a Representative Spectrum for Homogeneous Regions. Analyst 2015, 140, 2156–2163. [Google Scholar] [CrossRef] [PubMed]
  15. D’Antoni, A.V.; Tubbs, R.S.; Patti, A.C.; Higgins, Q.M.; Tiburzi, H.; Battaglia, F. The Critical Appraisal Tool for Anatomical Meta-analysis: A Framework for Critically Appraising Anatomical Meta-analyses. Clin. Anat. 2022, 35, 323–331. [Google Scholar] [CrossRef] [PubMed]
  16. Henry, B.M.; Tomaszewski, K.A.; Ramakrishnan, P.K.; Roy, J.; Vikse, J.; Loukas, M.; Tubbs, R.S.; Walocha, J.A. Development of the Anatomical Quality Assessment (AQUA) Tool for the Quality Assessment of Anatomical Studies Included in Meta-Analyses and Systematic Reviews. Clin. Anat. 2017, 30, 6–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Gurok, M.; Keles, D.; Korkmaz, S.; Yildirim, H.; Kilic, M.; Atmaca, M. Smaller Pituitary Volumes in Patients with Delusional Disorder. Med. Arch. 2019, 73, 253. [Google Scholar] [CrossRef] [PubMed]
  18. Polat, S.Ö.; Öksüzler, F.Y.; Öksüzler, M.; Uygur, A.G.; Yücel, A.H. The Determination of the Pituitary Gland, Optic Chiasm, and Intercavernous Distance Measurements in Healthy Subjects According to Age and Gender. Folia Morphol. 2020, 79, 28–35. [Google Scholar] [CrossRef]
  19. Whittle, S.; Barendse, M.; Pozzi, E.; Vijayakumar, N.; Simmons, J.G. Pubertal Hormones Predict Sex-Specific Trajectories of Pituitary Gland Volume during the Transition from Childhood to Adolescence. Neuroimage 2020, 204, 116256. [Google Scholar] [CrossRef]
  20. Atmaca, M.; Yildirim, H.; Yilmaz, S.; Caglar, N.; Baykara, S.; Kekilli, Y.; Koseoglu, F.; Turkcapar, H. Pituitary Gland Volumes in Patients with Obsessive-Compulsive Disorder before and after Cognitive-Behavioral Therapy. Rev. Bras. Psiquiatr. 2018, 40, 420–423. [Google Scholar] [CrossRef] [Green Version]
  21. Dumrongpisutikul, N.; Chuajak, A.; Lerdlum, S. Pituitary Height at Magnetic Resonance Imaging in Pediatric Isolated Growth Hormone Deficiency. Pediatr. Radiol. 2018, 48, 694–700. [Google Scholar] [CrossRef]
  22. Bozkurt Koseoglu, S.; Dinc Elibol, F. Does the Pituitary Gland Volume Change in Polycystic Ovary Syndrome? Gynecol. Obstet. Invest. 2018, 83, 515–519. [Google Scholar] [CrossRef]
  23. Premkumar, P.; Bream, D.; Sapara, A.; Fannon, D.; Anilkumar, A.P.; Kuipers, E.; Kumari, V. Pituitary Volume Reduction in Schizophrenia Following Cognitive Behavioural Therapy. Schizophr. Res. 2018, 192, 416–422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Singh, A.K.C.; Kandasamy, D.; Garg, A.; Jyotsna, V.P. Khadgawat R. Study of Pituitary Morphometry Using MRI in Indian Subjects. Indian J. Endocrinol. Metab. 2018, 22, 605–609. [Google Scholar] [CrossRef] [PubMed]
  25. Muneuchi, J.; Nagatomo, Y.; Okada, S.; Iida, C.; Shirozu, H.; Sugitani, Y.; Watanabe, M. Increased Pituitary Volumes in Children after Fontan Operation: Congestion in the Other Portal Circulation. J. Pediatr. 2018, 193, 249–251. [Google Scholar] [CrossRef] [PubMed]
  26. Atmaca, M.; Baykara, S.; Mermi, O.; Yildirim, H.; Akaslan, U. Pituitary Volumes Are Changed in Patients with Conversion Disorder. Brain Imaging Behav. 2016, 10, 92–95. [Google Scholar] [CrossRef] [PubMed]
  27. Unlu, E.; Unlu, B.S.; Turamanlar, O.; Acay, M.B.; Kacar, E.; Yıldız, Y.; Verim, O.; Okur, N.; Balcik, C.; Tasgetiren, S.; et al. Alterations in Pituitary Gland Volume in Polycystic Ovary Syndrome: A Structural Magnetic Resonance Imaging Study. Clin. Imaging 2015, 39, 449–453. [Google Scholar] [CrossRef]
  28. Clark, I.A.; Mackay, C.E.; Goodwin, G.M. Pituitary Gland Volumes in Bipolar Disorder. J. Affect. Disord. 2014, 169, 197–202. [Google Scholar] [CrossRef]
  29. Pieper, C.C.; Teismann, I.K.; Konrad, C.; Heindel, W.L.; Schiffbauer, H. Changes of Pituitary Gland Volume in Kennedy Disease. Am. J. Neuroradiol. 2013, 34, 2294–2297. [Google Scholar] [CrossRef] [Green Version]
  30. Takahashi, T.; Nakamura, K.; Nishiyama, S.; Furuichi, A.; Ikeda, E.; Kido, M.; Nakamura, Y.; Kawasaki, Y.; Noguchi, K.; Seto, H.; et al. Increased Pituitary Volume in Subjects at Risk for Psychosis and Patients with First-Episode Schizophrenia. Psychiatry. Clin. Neurosci. 2013, 67, 540–548. [Google Scholar] [CrossRef]
  31. van der Plas, E.; Caspell, C.J.; Aerts, A.M.; Tsalikian, E.; Richman, L.C.; Dawson, J.D.; Nopoulos, P. Height, BMI, and Pituitary Volume in Individuals with and without Isolated Cleft Lip and/or Palate. Pediatr. Res. 2012, 71, 612–618. [Google Scholar] [CrossRef] [Green Version]
  32. Yildirim, H.; Atmaca, M.; Sirlier, B.; Kayali, A. Pituitary Volumes Are Reduced in Patients with Somatization Disorder. Psychiatry Investig. 2012, 9, 278. [Google Scholar] [CrossRef]
  33. Kartalci, S.; Dogan, M.; Unal, S.; Ozcan, A.C.; Ozdemir, S.; Atmaca, M. Pituitary Volume in Patients with Panic Disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35, 203–207. [Google Scholar] [CrossRef] [PubMed]
  34. Takahashi, T.; Zhou, S.-Y.; Nakamura, K.; Tanino, R.; Furuichi, A.; Kido, M.; Kawasaki, Y.; Noguchi, K.; Seto, H.; Kurachi, M.; et al. Longitudinal Volume Changes of the Pituitary Gland in Patients with Schizotypal Disorder and First-Episode Schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35, 177–183. [Google Scholar] [CrossRef] [PubMed]
  35. Atmaca, M.; Yildirim, H.; Sec, S.; Kayali, A. Pituitary Volumes in Hypochondriac Patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34, 344–347. [Google Scholar] [CrossRef] [PubMed]
  36. Büschlen, J.; Berger, G.E.; Borgwardt, S.J.; Aston, J.; Gschwandtner, U.; Pflueger, M.O.; Kuster, P.; Radü, E.W.; Stieglitz, R.-D.; Riecher-Rössler, A. Pituitary Volume Increase during Emerging Psychosis. Schizophr. Res. 2011, 125, 41–48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Grams, A.E.; Gempt, J.; Stahl, A.; Förschler, A. Female Pituitary Size in Relation to Age and Hormonal Factors. Neuroendocrinology 2010, 92, 128–132. [Google Scholar] [CrossRef] [PubMed]
  38. Takahashi, T.; Walterfang, M.; Wood, S.J.; Kempton, M.J.; Jogia, J.; Lorenzetti, V.; Soulsby, B.; Suzuki, M.; Velakoulis, D.; Pantelis, C.; et al. Pituitary Volume in Patients with Bipolar Disorder and Their First-Degree Relatives. J. Affect. Disord. 2010, 124, 256–261. [Google Scholar] [CrossRef]
  39. Atmaca, M.; Yildirim, H.; Ozler, S.; Koc, M.; Kara, B.; Sec, S. Smaller Pituitary Volume in Adult Patients with Obsessive-Compulsive Disorder. Psychiatry Clin. Neurosci. 2009, 63, 516–520. [Google Scholar] [CrossRef]
  40. Garner, B.; Berger, G.E.; Nicolo, J.P.; Mackinnon, A.; Wood, S.J.; Pariante, C.M.; Dazzan, P.; Proffitt, T.M.; Markulev, C.; Kerr, M.; et al. Pituitary Volume and Early Treatment Response in Drug-Naïve First-Episode Psychosis Patients. Schizophr. Res. 2009, 113, 65–71. [Google Scholar] [CrossRef]
  41. Jung, M.H.; Huh, M.J.; Kang, D.-H.; Choi, J.-S.; Jung, W.H.; Jang, J.H.; Park, J.-Y.; Han, J.Y.; Choi, C.-H.; Kwon, J.S. Volumetric Differences in the Pituitary between Drug-Naïve and Medicated Male Patients with Obsessive–Compulsive Disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33, 605–609. [Google Scholar] [CrossRef]
  42. Lorenzetti, V.; Allen, N.B.; Fornito, A.; Pantelis, C.; de Plato, G.; Ang, A.; Yücel, M. Pituitary Gland Volume in Currently Depressed and Remitted Depressed Patients. Psychiatry Res. Neuroimaging 2009, 172, 55–60. [Google Scholar] [CrossRef]
  43. Takahashi, T.; Malhi, G.S.; Wood, S.J.; Walterfang, M.; Yücel, M.; Lorenzetti, V.; Soulsby, B.; Suzuki, M.; Velakoulis, D.; Pantelis, C. Increased Pituitary Volume in Patients with Established Bipolar Affective Disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33, 1245–1249. [Google Scholar] [CrossRef]
  44. Eker, C.; Ovali, G.Y.; Ozan, E.; Eker, O.D.; Kitis, O.; Coburn, K.; Gonul, A.S. No Pituitary Gland Volume Change in Medication-Free Depressed Patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32, 1628–1632. [Google Scholar] [CrossRef] [PubMed]
  45. Jovev, M.; Garner, B.; Phillips, L.; Velakoulis, D.; Wood, S.J.; Jackson, H.J.; Pantelis, C.; McGorry, P.D.; Chanen, A.M. An MRI Study of Pituitary Volume and Parasuicidal Behavior in Teenagers with First-Presentation Borderline Personality Disorder. Psychiatry. Res. Neuroimaging 2008, 162, 273–277. [Google Scholar] [CrossRef] [PubMed]
  46. de Aquino Miranda-Scippa, A.M.; Pires, M.L.N.; Handfas, B.W.; Marie, S.K.N.; Calil, H.M. Pituitary Volume and the Effects of Phototherapy in Patients with Seasonal Winter Depression: A Controlled Study. Rev. Bras. Psiquiatr. 2008, 30, 50–54. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Unlu, A.; Meco, C.; Ugur, H.C.; Comert, A.; Ozdemir, M.; Elhan, A. Endoscopic Anatomy of Sphenoid Sinus for Pituitary Surgery. Clin. Anat. 2008, 21, 627–632. [Google Scholar] [CrossRef] [PubMed]
  48. Yilmazlar, S.; Kocaeli, H.; Eyigor, O.; Hakyemez, B.; Korfali, E. Clinical Importance of the Basal Cavernous Sinuses and Cavernous Carotid Arteries Relative to the Pituitary Gland and Macroadenomas: Quantitative Analysis of the Complete Anatomy. Surg. Neurol. 2008, 70, 165–174. [Google Scholar] [CrossRef] [PubMed]
  49. Garner, B.; Chanen, A.M.; Phillips, L.; Velakoulis, D.; Wood, S.J.; Jackson, H.J.; Pantelis, C.; McGorry, P.D. Pituitary Volume in Teenagers with First-Presentation Borderline Personality Disorder. Psychiatry. Res. Neuroimaging 2007, 156, 257–261. [Google Scholar] [CrossRef]
  50. Gong, J.; Mohr, G.; Vézina, J.L. Endoscopic Pituitary Surgery with and without Image Guidance: An Experimental Comparison. Surg. Neurol. 2007, 67, 572–578. [Google Scholar] [CrossRef] [PubMed]
  51. Upadhyaya, A.; Elsheikh, R.; Macmaster, F.; Diwadkar, V.; Keshavan, M. Pituitary Volume in Neuroleptic-Naïve Schizophrenia: A Structural MRI Study. Schizophr. Res. 2007, 90, 266–273. [Google Scholar] [CrossRef]
  52. Garner, B.; Pariante, C.M.; Wood, S.J.; Velakoulis, D.; Phillips, L.; Soulsby, B.; Brewer, W.J.; Smith, D.J.; Dazzan, P.; Berger, G.E.; et al. Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis. Biol. Psychiatry 2005, 58, 417–423. [Google Scholar] [CrossRef]
  53. Argyropoulou, P.I.; Andronikou, S.; Argyropoulou, M.I.; Kiortsis, D.; Xydis, V.; Drougia, A.G.; Efremidis, S.C. The Height of the Pituitary in Preterm Infants during the First 2 Years of Life: An MRI Study. Neuroradiology 2004, 46, 224–226. [Google Scholar] [CrossRef]
  54. Bolu, S.E.; Tasar, M.; Üçkaya, G.; Gönül, E.; Deniz, F.; Özdemir, I.Ç. Increased Abnormal Pituitary Findings on Magnetic Resonance in Patients with Male Idiopathic Hypogonadotrophic Hypogonadism. J. Endocrinol. Invest. 2004, 27, 1029–1033. [Google Scholar] [CrossRef]
  55. Kornreich, L.; Horev, G.; Schwarz, M.; Karmazyn, B.; Laron, Z. Pituitary Size in Patients with Laron Syndrome (Primary GH Insensitivity). Eur. J. Endocrinol. 2003, 339–341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Sassi, R.B.; Nicoletti, M.; Brambilla, P.; Harenski, K.; Mallinger, A.G.; Frank, E.; Kupfer, D.J.; Keshavan, M.S.; Soares, J.C. Decreased Pituitary Volume in Patients with Bipolar Disorder. Biol. Psychiatry 2001, 50, 271–280. [Google Scholar] [CrossRef] [PubMed]
  57. Takano, K.; Utsunomiya, H.; Ono, H.; Ohfu, M.; Okazaki, M. Normal Development of the Pituitary Gland: Assessment with Three-Dimensional MR Volumetry. AJNR Am. J. Neuroradiol. 1999, 20, 312–315. [Google Scholar] [PubMed]
  58. Dinç, H.; Esen, F.; Demirci, A.; Sari, A.; Gümele, H.R. Pituitary Dimensions and Volume Measurements in Pregnancy and Post Partum. Acta Radiol. 1998, 39, 64–69. [Google Scholar] [CrossRef]
  59. Sato, N.; Putman, C.M.; Chaloupka, J.C.; Glenn, B.J.; Vinuela, F.; Sze, G. Pituitary Gland Enlargement Secondary to Dural Arteriovenous Fistula in the Cavernous Sinus: Appearance at MR Imaging. Radiology 1997, 203, 263–267. [Google Scholar] [CrossRef]
  60. Schwartz, P.J.; Loe, J.A.; Bash, C.N.; Bove, K.; Turner, E.H.; Frank, J.A.; Wehr, T.A.; Rosenthal, N.E. Seasonality and Pituitary Volume. Psychiatry Res. Neuroimaging 1997, 74, 151–157. [Google Scholar] [CrossRef] [PubMed]
  61. Tsunoda, A.; Okuda, O.; Sato, K. MR Height of the Pituitary Gland as a Function of Age and Sex: Especially Physiological Hypertrophy in Adolescence and in Climacterium. AJNR Am. J. Neuroradiol. 1997, 18, 551–554. [Google Scholar] [PubMed]
  62. Desai, M.P. Pituitary Enlargement on Magnetic Resonance Imaging in Congenital Hypothyroidism. Arch. Pediatr. Adolesc. Med. 1996, 150, 623. [Google Scholar] [CrossRef] [PubMed]
  63. Chong, B.W.; Kucharczyk, W.; Singer, W.; George, S. Pituitary Gland MR: A Comparative Study of Healthy Volunteers and Patients with Microadenomas. AJNR Am. J. Neuroradiol. 1994, 15, 675–679. [Google Scholar]
  64. Teoh, S.K.; Mendelson, J.H.; Woods, B.T.; Mello, N.K.; Hallgring, E.; Anfinsen, P.; Douglas, A.; Mercer, G. Pituitary Volume in Men with Concurrent Heroin and Cocaine Dependence. J. Clin. Endocrinol. Metab. 1993, 76, 1529–1532. [Google Scholar] [CrossRef] [PubMed]
  65. Axelson, D.A.; Doraiswamy, P.M.; Boyko, O.B.; Escalona, P.R.; McDonald, W.M.; Ritchie, J.C.; Patterson, L.J.; Ellinwood, E.H.; Nemeroff, C.B.; Krishnan, K.R.R. In Vivo Assessment of Pituitary Volume with Magnetic Resonance Imaging and Systematic Stereology: Relationship to Dexamethasone Suppression Test Results in Patients. Psychiatry Res. 1992, 44, 63–70. [Google Scholar] [CrossRef] [PubMed]
  66. Cox, T.D.; Elster, A.D. Normal Pituitary Gland: Changes in Shape, Size, and Signal Intensity during the 1st Year of Life at MR Imaging. Radiology 1991, 179, 721–724. [Google Scholar] [CrossRef] [PubMed]
  67. Doraiswamy, P.M.; Potts, J.M.; Axelson, D.A.; Husain, M.M.; Lurie, S.N.; Na, C.; Escalona, P.R.; McDonald, W.M.; Figiel, G.S.; Ellinwood, E.H. MR Assessment of Pituitary Gland Morphology in Healthy Volunteers: Age- and Gender-Related Differences. AJNR Am. J. Neuroradiol. 1992, 13, 1295–1299. [Google Scholar] [PubMed]
  68. Elster, A.D.; Sanders, T.G.; Vines, F.S.; Chen, M.Y. Size and Shape of the Pituitary Gland during Pregnancy and Post Partum: Measurement with MR Imaging. Radiology 1991, 181, 531–535. [Google Scholar] [CrossRef] [PubMed]
  69. Krishnan, K.R.R.; Doraiswamy, P.M.; Lurie, S.N.; Figiel, G.S.; Husain, M.M.; Boyko, O.B.; Ellinwood, E.H.; Nemeroff, C.B. Pituitary Size in Depression. J. Clin. Endocrinol. Metab. 1991, 72, 256–259. [Google Scholar] [CrossRef] [PubMed]
  70. Konishi, Y.; Kuriyama, M.; Sudo, M.; Hayakawa, K.; Konishi, K.; Nakamura, K. Growth Patterns of the Normal Pituitary Gland and in Pituitary Adenoma. Dev. Med. Child. Neurol. 1990, 32, 69–73. [Google Scholar] [CrossRef] [PubMed]
  71. Argyropoulou, M.; Perignon, F.; Brunelle, F.; Brauner, R.; Rappaport, R. Height of Normal Pituitary Gland as a Function of Age Evaluated by Magnetic Resonance Imaging in Children. Pediatr. Radiol. 1991, 21, 247–249. [Google Scholar] [CrossRef] [PubMed]
  72. Lurie, S.N.; Doraiswamy, P.M.; Husain, M.M.; Boyko, O.B.; Ellinwood, E.H.; Figiel, G.S.; Krishnan, K.R.R. In Vivo Assessment of Pituitary Gland Volume with Magnetic Resonance Imaging: The Effect of Age. J. Clin. Endocrinol. Metab. 1990, 71, 505–508. [Google Scholar] [CrossRef]
  73. Murali Doraiswamy, P.; Ranga Rama Krishnan, K.; Figiel, G.S.; Husain, M.M.; Boyko, O.B.; Kenneth Rockwell, W.J.; Ellinwood, E.H. A Brain Magnetic Resonance Imaging Study of Pituitary Gland Morphology in Anorexia Nervosa and Bulimia. Biol. Psychiatry 1990, 28, 110–116. [Google Scholar] [CrossRef] [PubMed]
  74. Suzuki, M.; Takashima, T.; Kadoya, M.; Konishi, H.; Kameyama, T.; Yoshikawa, J.; Gabata, T.; Arai, K.; Tamura, S.; Yamamoto, T.; et al. Height of Normal Pituitary Gland on MR Imaging. J. Comput. Assist. Tomogr. 1990, 14, 36–39. [Google Scholar] [CrossRef] [PubMed]
  75. Gonzalez, J.G.; Elizondo, G.; Saldivar, D.; Nanez, H.; Todd, L.E.; Villarreal, J.Z. Pituitary Gland Growth during Normal Pregnancy: An in Vivo Study Using Magnetic Resonance Imaging. Am. J. Med. 1988, 85, 217–220. [Google Scholar] [CrossRef] [PubMed]
  76. Lim, T.H.; Chang, K.H.; Han, M.C.; Chang, Y.B.; Lim, S.M.; Yu, Y.S.; Chun, Y.H.; Lee, J.S. Pituitary Atrophy in Korean (Epidemic) Hemorrhagic Fever: CT Correlation with Pituitary Function and Visual Field. AJNR Am. J. Neuroradiol. 1986, 7, 633–637. [Google Scholar]
  77. Wiener, S.N.; Rzeszotarski, M.S.; Droege, R.T.; Pearlstein, A.E.; Shafron, M. Measurement of Pituitary Gland Height with MR Imaging. AJNR Am. J. Neuroradiol. 1985, 6, 717–722. [Google Scholar] [PubMed]
  78. Mark, L.; Pech, P.; Daniels, D.; Charles, C.; Williams, A.; Haughton, V. The Pituitary Fossa: A Correlative Anatomic and MR Study. Radiology 1984, 153, 453–457. [Google Scholar] [CrossRef] [PubMed]
  79. Peyster, R.G.; Adler, L.P.; Viscarello, R.R.; Hoover, E.D.; Skarzynski, J. CT of the Normal Pituitary Gland. Neuroradiology 1986, 28, 161–165. [Google Scholar] [CrossRef]
  80. Muhr, C.; Bergstrom, K.; Grimelius, L.; Larsson, S.-G. A Parallel Study of the Roentgen Anatomy of the Sella Turcica and the Histopathology of the Pituitary Gland in 205 Autopsy Specimens. Neuroradiology 1981, 21, 55–65. [Google Scholar] [CrossRef]
  81. Castillo, M. Pituitary gland: Development, normal appearances, and magnetic resonance imaging protocols. Top. Magn. Reson. Imaging 2005, 16, 259–268. [Google Scholar] [CrossRef]
  82. Miki, Y.; Asato, R.; Okumura, R.; Togashi, K.; Kimura, I.; Kawakami, S.; Konishi, J. Anterior Pituitary Gland in Pregnancy: Hyperintensity at MR. Radiology 1993, 187, 229–231. [Google Scholar] [CrossRef]
  83. Denk, C.; Onderoğlu, S.; Ilgi, S.; Gurcan, F. Height of Normal Pituitary Gland on MRI: Differences between Age Groups and Sexes. Okajimas Folia Anat. Jpn. 1999, 76, 81–87. [Google Scholar] [CrossRef] [Green Version]
  84. Solari, D.; Pivonello, R.; Caggiano, C.; Guadagno, E.; Chiaramonte, C.; Miccoli, G.; Cavallo, L.M.; del Basso De Caro, M.; Colao, A.; Cappabianca, P. Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us? World Neurosurg. 2019, 127, 695–709. [Google Scholar] [CrossRef] [PubMed]
  85. Youssef, A.S.; Agazzi, S.; van Loveren, H.R. Transcranial Surgery for Pituitary Adenomas. Oper. Neurosurg. 2005, 57, 168–175. [Google Scholar] [CrossRef] [PubMed]
  86. Teramoto, A.; Hirakawa, K.; Sanno, N.; Osamura, Y. Incidental Pituitary Lesions in 1,000 Unselected Autopsy Specimens. Radiology 1994, 193, 161–164. [Google Scholar] [CrossRef]
  87. Elster, A.D. Modern Imaging of the Pituitary. Radiology 1993, 187, 1–14. [Google Scholar] [CrossRef]
  88. Ishikawa, T.; Zhu, B.-L.; Li, D.-R.; Zhao, D.; Michiue, T.; Maeda, H. Age-Dependent Increase of Clusterin in the Human Pituitary Gland. Leg. Med. 2006, 8, 28–33. [Google Scholar] [CrossRef] [PubMed]
  89. Foster, E.M.; Dangla-Valls, A.; Lovestone, S.; Ribe, E.M.; Buckley, N.J. Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies. Front. Neurosci. 2019, 13, 164. [Google Scholar] [CrossRef] [Green Version]
  90. Webber, K.M.; Casadesus, G.; Atwood, C.S.; Bowen, R.L.; Perry, G.; Smith, M.A. Gonadotropins: A Cohesive Gender-Based Etiology of Alzheimer Disease. Mol. Cell Endocrinol. 2007, 260–262, 271–275. [Google Scholar] [CrossRef]
  91. Bowen, R.L.; Verdile, G.; Liu, T.; Parlow, A.F.; Perry, G.; Smith, M.A.; Martins, R.N.; Atwood, C.S. Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-β Precursor Protein and Amyloid-β Deposition. J. Biol. Chem. 2004, 279, 20539–20545. [Google Scholar] [CrossRef] [Green Version]
  92. Knopman, D.S.; DeKosky, S.T.; Cummings, J.L.; Chui, H.; Corey–Bloom, J.; Relkin, N.; Small, G.W.; Miller, B.; Stevens, J.C. Practice Parameter: Diagnosis of Dementia (an Evidence-Based Review). Neurology 2001, 56, 1143–1153. [Google Scholar] [CrossRef] [Green Version]
  93. Li, Y.-H.; Peng, X.-D.; Huang, C.-Q.; Yang, B.; Liu, Q.-X. Hypothalamic-Pituitary-Thyroid Axis in Patients with Alzheimer Disease (AD). J. Investig. Med. 2013, 61, 578–581. [Google Scholar] [CrossRef]
Figure 1. Flow diagram presenting the process of collecting the data included in this meta-analysis.
Figure 1. Flow diagram presenting the process of collecting the data included in this meta-analysis.
Brainsci 13 00089 g001
Figure 2. Diagram presenting differences in the heights of the pituitary gland (PG) between male and female patients and different age groups. Statistically significant differences are noted between the females and males in the age group 20-29 (p < 0.001).
Figure 2. Diagram presenting differences in the heights of the pituitary gland (PG) between male and female patients and different age groups. Statistically significant differences are noted between the females and males in the age group 20-29 (p < 0.001).
Brainsci 13 00089 g002
Figure 3. Pituitary gland on the sagittal cross-section of a human cadaver head. (A) general view; (B) magnification showing the sellar region. ds, dorsum sellae; oc, optic chiasm; on, optic nerve; ss, sphenoid sinus; tc, tuber cinereum; white asterisk, pituitary stalk; violet asterisk, anterior pituitary (front lobe); navy asterisk, posterior pituitary (back lobe).
Figure 3. Pituitary gland on the sagittal cross-section of a human cadaver head. (A) general view; (B) magnification showing the sellar region. ds, dorsum sellae; oc, optic chiasm; on, optic nerve; ss, sphenoid sinus; tc, tuber cinereum; white asterisk, pituitary stalk; violet asterisk, anterior pituitary (front lobe); navy asterisk, posterior pituitary (back lobe).
Brainsci 13 00089 g003
Table 1. Characteristics of the studies included in this meta-analysis.
Table 1. Characteristics of the studies included in this meta-analysis.
First AuthorYearContinentCountryMethodPatients
Gurok et al. [17]2019AsiaTurkeyMRI18
Polat et al. [18]2020AsiaTurkeyMRI292
Whittle et al. [19]2020AustraliaAustraliaMRI409
Atmaca et al. [20]2018AsiaTurkeyMRI12
Dumrongpisutikul et al. [21]2018AsiaThailandMRI70
Bozkurt Koseoglu and Dinc Elibol [22]2018AsiaTurkeyMRI42
Premkumar et al. [23]2018EuropeUKMRI30
Singh et al. [24]2018AsiaIndiaMRI482
Pecina et al. [11]2017EuropeCroatiaMRI199
Muneuchi et al. [25]2018AsiaJapanMRI40
Atmaca et al. [26]2016AsiaTurkeyMRI20
Unlu et al. [27]2015AsiaTurkeyMRI31
Clark et al. [28]2014EuropeEnglandMRI74
Pieper et al. [29]2013EuropeGermanyMRI16
Takahashi et al. [30]2013AsiaJapanMRI86
van der Plas E. et al. [31]2012North AmericaUSAMRI279
Gruner et al. [7]2012North AmericaUSAMRI59
Yildirim et al. [32]2012AsiaTurkeyMRI18
Kartalci et al. [33]2011AsiaTurkeyMRI27
Klomp et al. [8]2012EuropeNetherlandsMRI156
Takahashi et al. [34]2011AsiaJapanMRI40
Atmaca et al. [35]2010AsiaTurkeyMRI20
Büschlen et al. [36]2011EuropeSwitzerlandMRI20
Ertekin et al. [13]2011AsiaTurkeyMRI28
Grams et al. [37]2010EuropeGermanyMRI94
Nicolo et al. [10]2010AustraliaAustraliaMRI48
Takahashi et al. [38]2010EuropeUKMRI52
Atmaca et al. [39]2009AsiaTurkeyMRI23
Garner et al. [40]2009OceaniaAustraliaMRI42
Jung et al. [41]2009AsiaSouth KoreaMRI62
Lorenzetti et al. [42]2009OceaniaAustraliaMRI33
Takahashi et al. [43]2009AustraliaAustraliaMRI122
Eker et al. [44]2008AsiaTurkeyMRI39
Jovev et al. [45]2008OceaniaAustraliaMRI20
Miranda-Scippa et al. [46]2008South AmericaBrazilMRI24
Unlu et al. [47]2008AsiaTurkeyCadavers5
Yilmazlar et al. [48]2008AsiaTurkeyCadavers49
Garner et al. [49]2007OceaniaAustraliaMRI20
Gong et al. [50]2007North AmericaCanadaCadavers42
Upadhyaya et al. [51]2007North AmericaUSAMRI55
Garner et al. [52]2005OceaniaAustraliaMRI49
Miki et al. [12]2005AsiaJapanMRI13
Argyropoulou et al. [53]2004EuropeGreeceMRI70
Bolu et al. [54]2004AsiaTurkeyMRI49
Chen et al. [5]2004North AmericaUSAMRI21
Macmaster et al. [9]2004North AmericaCanadaMRI17
Kornreich et al. [55]2003AsiaIsrealMRI9
Sassi et al. [56]2001North AmericaUSAMRI34
Takano et al. [57]1999AsiaJapanMRI199
Dinç et al. [58]1998EuropeDenmarkMRI18
Sato et al. [59]1997North AmericaUSAMRI12
Schwartz et al. [60]1997North AmericaUSAMRI19
Tsunoda et al. [61]1997AsiaJapanMRI1020
Desai et al. [62]1996AsiaIndiaMRI10
Chong et al. [63]1994North AmericaCanadaMRI52
Teoh et al. [64]1993North AmericaUSAMRI8
Axelson et al. [65]1992EuropeIrelandMRI24
Cox [66]1991North AmericaUSAMRI48
Doraiswamy et al. [67]1992North AmericaUSAMRI85
Elster et al. [68]1991North AmericaUSAMRI30
Krishnan et al. [69]1991North AmericaUSAMRI19
Konishi et al. [70]1990Asia-MRI101
Argyropoulou et al. [71]1991EuropeFranceMRI60
Lurie et al. [72]1990North AmericaUSAMRI25
Murali et al. [73]1990North AmericaUSAMRI13
Suzuki et al. [74]1990AsiaJapanMRI213
Gonzalez et al. [75]1988North AmericaMexicoMRI20
Lim et al. [76]1986AsiaSouth KoreaCT11
Wiener et al. [77]1985North AmericaUSAMRI42
Mark et al. [78]1984North AmericaUSAMRI38
Peyster et al. [79]1986North AmericaUSACT27
Muhr et al. [80]1981EuropeSwedenMRI205
Table 2. Results of this meta-analysis regarding the morphometric parameters of the pituitary gland (PG) in adults. LCI, lower confidence interval; HCI, higher confidence interval; Q, Cochran’s Q.
Table 2. Results of this meta-analysis regarding the morphometric parameters of the pituitary gland (PG) in adults. LCI, lower confidence interval; HCI, higher confidence interval; Q, Cochran’s Q.
CategoryNMeanStandard ErrorVarianceLower LimitUpper LimitZ-Value
Volume of the PG (mm3)
Overall1349597.2328.81830.09540.76653.7020.73
Females508587.3641.761744.19505.50669.2114.06
Males494508.8727.95781.08454.09563.6418.21
Asia430669.6071.895168.50528.69810.509.31
Asian Females84706.69110.2612,157.12490.59922.806.41
Asian Males123642.0453.262836.19537.66746.4212.06
Australia81634.5874.635570.01488.30780.868.50
Australian Females38591.6243.761914.86505.85677.3813.52
Australian Males43531.5634.461187.23464.03599.0915.43
Europe515562.5133.391115.23497.06627.9616.84
European Females319620.0987.987740.12447.66792.537.05
European Males196456.4223.49551.59410.39502.4619.43
North America279516.5945.892106.05426.64606.5411.26
North American Females44584.53108.6111,795.77371.66797.405.38
North American Males46535.0993.798797.21351.26718.925.70
South America24626.9128.10789.86571.82681.9922.31
Height of the PG (mm)
Overall (MRI + cadavers)7875.640.110.015.415.8649.62
MRI7125.350.140.025.075.6337.92
Cadavers755.740.200.045.356.1328.60
Females3425.400.140.025.135.6838.31
Males1714.960.120.014.735.1843.05
Asia1206.030.470.225.116.9612.82
Asian Females384.920.080.014.765.0861.94
Asian Males824.700.120.014.474.9240.55
Europe3175.750.210.055.336.1726.98
North America3795.550.160.035.245.8634.73
North American Females625.590.350.124.906.2815.87
North American Males514.910.510.263.915.919.62
Length of the PG (mm)
Overall3639.980.260.079.4610.4937.89
Females12010.030.340.119.3710.6929.83
Males1339.830.460.218.9210.7321.36
Asia779.380.910.837.6011.1610.31
Europe11210.040.340.119.3810.7029.81
North America17410.130.340.119.4710.7929.99
Width of the PG (mm)
Overall (MRI + cadavers)37713.081.763.109.6316.537.43
MRI30213.180.720.5211.7614.5918.24
Cadavers7515.261.371.8712.5717.9411.14
Females29413.140.270.0712.6013.6748.46
Males8312.910.260.0712.3913.4348.77
Asia8217.531.472.1714.6420.4111.90
Europe11213.920.370.1313.2014.6337.96
North America18312.710.590.3511.5513.8621.56
Pituitary Area (mm2)
Overall15438.062.325.4033.5142.6216.38
Females3241.596.5743.2328.7054.486.33
Males1636.001.753.0632.5739.4320.57
Infundibulum (mm)
Width182.100.070.011.962.2429.70
CategoryNPooled PrevalenceLCIHCIQI2
Shape of the PG
Convex30958.38%22.21%90.65%171.4995.33
Concave30917.72%5.63%34.00%43.9581.80
Flat30916.67%0.00%47.07%135.9194.11
Partially empty sella3092.20%0.00%7.16%16.3250.97
Table 3. Results of this meta-analysis regarding the morphometric parameters of the pituitary gland (PG) in children (under 18 years old). LCI, lower confidence interval; HCI, higher confidence interval; Q, Cochran’s Q.
Table 3. Results of this meta-analysis regarding the morphometric parameters of the pituitary gland (PG) in children (under 18 years old). LCI, lower confidence interval; HCI, higher confidence interval; Q, Cochran’s Q.
CategoryNMeanStandard ErrorVarianceLower LimitUpper LimitZ-Value
Volume of the PG (mm3)
Overall212511.53112.4512,644.01291.14731.924.55
Females101450.8848.902391.31355.03546.729.22
Australian Females 32349.187.6858.93334.14364.2345.49
Males111453.5046.522164.44362.32544.699.75
Australian Males46365.0430.37922.64305.50424.5712.02
North America78513.86155.4324,158.38209.23818.503.31
Height of the PG (mm)
Overall3414.810.550.303.735.898.72
Females166.600.500.255.627.5813.20
Males165.400.530.284.376.4310.29
Asia2115.370.240.064.905.8422.37
Europe1303.940.670.452.625.255.85
Width of the PG (mm)
Asia4010.800.070.0110.6610.94151.79
Pituitary Area (mm2)
Asia10129.981.101.2027.8332.1327.32
CategoryNPooled PrevalenceLCIHCIQI2
Shape of the PG
Convex15454.03%22.55%84.05%38.1592.14
Concave15412.16%6.92%18.58%3.5314.97
Flat15433.10%7.87%64.05%35.2591.49
Table 4. Results of this meta-analysis regarding the height of the pituitary gland (PG) with respect to the age groups of the patients.
Table 4. Results of this meta-analysis regarding the height of the pituitary gland (PG) with respect to the age groups of the patients.
CategoryMeanStandard ErrorVarianceLower LimitUpper LimitZ-Valuep-Value
Height of the PG (mm)
Females
10–19
years old
6.160.230.055.726.6127.09<0.001
Males
10–19
years old
5.350.300.094.775.9318.10<0.001
Females
20–29
years old
6.470.110.016.256.6858.47<0.001
Males
20–29
years old
5.650.130.025.395.9043.31<0.001
Females
30–39
years old
5.680.170.035.366.0133.92<0.001
Males
30–39
years old
5.360.140.025.085.6537.43<0.001
Females
40–49
years old
5.330.230.054.885.7723.61<0.001
Males
40–49
years old
4.880.100.014.685.0848.40<0.001
Females
50–59
years old
5.070.420.174.265.8912.17<0.001
Males
50–59
years old
4.710.170.034.395.0428.41<0.001
Females
60–69
years old
4.880.090.014.715.0654.94<0.001
Males
60–69
years old
4.530.290.083.975.1015.81< 0.001
Females
70+
years old
4.520.470.223.615.439.69<0.001
Males
70+
years old
4.770.100.014.594.9649.83<0.001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bonczar, M.; Wysiadecki, G.; Ostrowski, P.; Michalczak, M.; Plutecki, D.; Wilk, J.; Michalik, W.; Walocha, J.; Balawender, K.; Iskra, T.; et al. The Morphology of the Pituitary Gland: A Meta-Analysis with Implications for Diagnostic Imaging. Brain Sci. 2023, 13, 89. https://doi.org/10.3390/brainsci13010089

AMA Style

Bonczar M, Wysiadecki G, Ostrowski P, Michalczak M, Plutecki D, Wilk J, Michalik W, Walocha J, Balawender K, Iskra T, et al. The Morphology of the Pituitary Gland: A Meta-Analysis with Implications for Diagnostic Imaging. Brain Sciences. 2023; 13(1):89. https://doi.org/10.3390/brainsci13010089

Chicago/Turabian Style

Bonczar, Michał, Grzegorz Wysiadecki, Patryk Ostrowski, Mateusz Michalczak, Dawid Plutecki, Jakub Wilk, Weronika Michalik, Jerzy Walocha, Krzysztof Balawender, Tomasz Iskra, and et al. 2023. "The Morphology of the Pituitary Gland: A Meta-Analysis with Implications for Diagnostic Imaging" Brain Sciences 13, no. 1: 89. https://doi.org/10.3390/brainsci13010089

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop